Home > PJ > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7182 p81-86
26 January 2002

This article
Reprint
Photocopy


News summary


PCTs asked to integrate pharmacy into their local clinical governance plans

Primary care trusts in England have been asked to start integrating community pharmacy into their local clinical governance arrangements even though this is not yet part of pharmacy's terms of service.

Guidance issued by the Department of Health on 17 January says that by April PCTs should have identified clinical governance leads within PCTs, and among local community pharmacists, and to have established communication links between them. Community pharmacy should be represented on clinical governance committees and be included in plans for 2002–03. A community pharmacy clinical governance baseline assessment should be carried out, if it has not already been conducted (see Panel).

Baseline assessment

In terms of the baseline assessment, the Royal Pharmaceutical Society's questionnaire (PDF* 50K), with or without local modifications, is recommended. Face-to-face visits may help with securing maximum responses to this. However, the guidance says that the Society's assessment mainly deals with dispensing and more work is needed on advice given by pharmacists, over-the-counter sales and referrals to other primary care team members.

The guidance says: "At present, community pharmacies are not required by their terms of service to participate in local clinical governance arrangements. The Government has said that this will be one of the issues to be addressed when the national contractual framework is modernised." Meanwhile, progress is to be made by encouraging voluntary activity and by ensuring that clinical governance is built into any local pharmaceutical services pilot schemes. The Department of Health is to provide funding of up to £2m a year to support clinical governance in community pharmacy.

Clinical governance in Stockport

Roger Roberts, pharmaceutical adviser to Stockport Health Authority and Primary Care Trust, said that the authority had spent a lot of time making pharmacists aware of clinical governance and helping them get to grips with it.

Stockport is highlighted in the guidance for its panel for poorly performing pharmacists and its "Going for gold" pharmacy accreditation scheme. Mr Roberts said that the panel aims to pick up on information passed to it and to prevent pharmacists getting into serious problems.

The panel consists of representatives of the health authority, the local pharmaceutical committee and the Centre for Postgraduate Pharmaceutical Education. It is chaired by a health authority manager who also chairs a similar panel for doctors. The panel visits pharmacies and encourages the pharmacists to join its accreditation scheme.

Around half the 62 pharmacies in Stockport have now achieved the initial bronze level of accreditation and two have reached silver, for which they receive payments of £750 or £1,000 a year, respectively.

Sue Sharpe, chief executive of the Pharmaceutical Services Negotiating Committee, said that the PSNC is generally supportive of the guidance and the way in which it seeks to integrate community pharmacy into PCTs' clinical governance structures.

However, the PSNC wants to see proper funding to be put in place for clinical governance participation, pointing out that the £2m funding will not go far among 10,000 contractors.

Some community pharmacy companies have already taken steps to implement clinical governance, but the guidance notes that "shifts will be needed in the culture and practice of community pharmacy if clinical governance is to be sustained".

Local clinical governance leads should be pharmacists with current or recent experience of community pharmacy, the guidance says, and ownership of the role by local community pharmacists is essential.

In order to sustain clinical governance in the community, PCTs will have to provide schemes that are commercially positive or neutral and which can be used to enhance patients' perceptions of customer care in pharmacies leading to customer retention, the guidance says.

Copies of the guidance "Clinical governance in community pharmacy: guidelines on good practice in the NHS" have been sent to health authorities, primary care trusts and community pharmacies. Additional copies can be downloaded from the internet.

For a detailed explanation of the guidance click here.

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal